RT Journal Article
SR Electronic
T1 Systematic review and meta-analysis of the association between Epstein-Barr virus, Multiple Sclerosis, and other risk factors
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 19007450
DO 10.1101/19007450
A1 Benjamin M Jacobs
A1 Gavin Giovannoni
A1 Jack Cuzick
A1 Ruth Dobson
YR 2019
UL http://medrxiv.org/content/early/2019/09/25/19007450.abstract
AB Background EBV infection is thought to play a central role in the development of Multiple Sclerosis (MS). If causal, it represents a target for interventions to reduce MS risk.Objective To examine the evidence for interaction between EBV and other risk factors, and explore mechanisms via which EBV infection may influence MS risk.Methods Pubmed was searched using the terms “multiple sclerosis” AND “Epstein Barr virus”, “multiple sclerosis” AND EBV, “clinically isolated syndrome” AND “Epstein Barr virus” and “clinically isolated syndrome” AND EBV. All abstracts were reviewed for possible inclusion.Results 262 full-text papers were reviewed. There was evidence of interaction on the additive scale between anti-EBV antibody titre and HLA genotype (AP 0.48, p<1×10−4; RERI 3.84, p<5×10−3; S 1.68, p=0.06). Previous IM was associated with increased OR of MS in HLA-DRB1*1501 positive but not HLA-DRB1*1501 negative persons. Smoking was associated with a greater risk of MS in those with high anti-EBV antibodies (OR 2.76) but not low anti-EBV antibodies (OR 1.16). No interaction between EBV and risk factors was found on a multiplicative scale.Conclusions EBV appears to interact with at least some established MS risk factors. The mechanism via which EBV influences MS risk remains unknown.Competing Interest StatementSee manuscriptFunding StatementSee manuscriptAuthor DeclarationsAll relevant ethical guidelines have been followed and any necessary IRB and/or ethics committee approvals have been obtained.Not ApplicableAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.Not ApplicableAny clinical trials involved have been registered with an ICMJE-approved registry such as ClinicalTrials.gov and the trial ID is included in the manuscript.Not ApplicableI have followed all appropriate research reporting guidelines and uploaded the relevant Equator, ICMJE or other checklist(s) as supplementary files, if applicable.Not ApplicableAll data are publicly available